Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
15th National Conference of the IAOMFP, Chennai, 2006
Abstract
Abstracts from current literature
Acne in India: Guidelines for management - IAA Consensus Document
Addendum
Announcement
Art & Psychiatry
Article
Articles
Association Activities
Association Notes
Award Article
Book Review
Brief Report
Case Analysis
Case Letter
Case Letters
Case Notes
Case Report
Case Reports
Clinical and Laboratory Investigations
Clinical Article
Clinical Studies
Clinical Study
Commentary
Conference Oration
Conference Summary
Continuing Medical Education
Correspondence
Corrigendum
Cosmetic Dermatology
Cosmetology
Current Best Evidence
Current Issue
Current View
Derma Quest
Dermato Surgery
Dermatopathology
Dermatosurgery Specials
Dispensing Pearl
Do you know?
Drug Dialogues
e-IJDVL
Editor Speaks
Editorial
Editorial Remarks
Editorial Report
Editorial Report - 2007
Editorial report for 2004-2005
Errata
Erratum
Focus
Fourth All India Conference Programme
From Our Book Shelf
From the Desk of Chief Editor
General
Get Set for Net
Get set for the net
Guest Article
Guest Editorial
History
How I Manage?
IADVL Announcement
IADVL Announcements
IJDVL Awards
IJDVL AWARDS 2015
IJDVL Awards 2018
IJDVL Awards 2019
IJDVL Awards 2020
IJDVL International Awards 2018
Images in Clinical Practice
Images in Dermatology
In Memorium
Inaugural Address
Index
Knowledge From World Contemporaries
Leprosy Section
Letter in Response to Previous Publication
Letter to Editor
Letter to the Editor
Letter to the Editor - Case Letter
Letter to the Editor - Letter in Response to Published Article
LETTER TO THE EDITOR - LETTERS IN RESPONSE TO PUBLISHED ARTICLES
Letter to the Editor - Observation Letter
Letter to the Editor - Study Letter
Letter to the Editor - Therapy Letter
Letter to the Editor: Articles in Response to Previously Published Articles
Letters in Response to Previous Publication
Letters to the Editor
Letters to the Editor - Letter in Response to Previously Published Articles
Letters to the Editor: Case Letters
Letters to the Editor: Letters in Response to Previously Published Articles
Media and news
Medicolegal Window
Messages
Miscellaneous Letter
Musings
Net Case
Net case report
Net Image
Net Images
Net Letter
Net Quiz
Net Study
New Preparations
News
News & Views
Obituary
Observation Letter
Observation Letters
Oration
Original Article
ORIGINAL CONTRIBUTION
Original Contributions
Pattern of Skin Diseases
Pearls
Pediatric Dermatology
Pediatric Rounds
Perspective
Presedential Address
Presidential Address
Presidents Remarks
Quiz
Recommendations
Regret
Report
Report of chief editor
Report of Hon : Treasurer IADVL
Report of Hon. General Secretary IADVL
Research Methdology
Research Methodology
Resident page
Resident's Page
Resident’s Page
Residents' Corner
Residents' Corner
Residents' Page
Retraction
Review
Review Article
Review Articles
Reviewers 2022
Revision Corner
Self Assessment Programme
SEMINAR
Seminar: Chronic Arsenicosis in India
Seminar: HIV Infection
Short Communication
Short Communications
Short Report
Snippets
Special Article
Specialty Interface
Studies
Study Letter
Study Letters
Supplement-Photoprotection
Supplement-Psoriasis
Symposium - Contact Dermatitis
Symposium - Lasers
Symposium - Pediatric Dermatoses
Symposium - Psoriasis
Symposium - Vesicobullous Disorders
SYMPOSIUM - VITILIGO
Symposium Aesthetic Surgery
Symposium Dermatopathology
Symposium-Hair Disorders
Symposium-Nails Part I
Symposium-Nails-Part II
Systematic Review and Meta-Analysis
Systematic Reviews and Meta-analyses
Systematic Reviews and Meta-analysis
Tables
Technology
Therapeutic Guideline-IADVL
Therapeutic Guidelines
Therapeutic Guidelines - IADVL
Therapeutics
Therapy
Therapy Letter
Therapy Letters
View Point
Viewpoint
What’s new in Dermatology
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
15th National Conference of the IAOMFP, Chennai, 2006
Abstract
Abstracts from current literature
Acne in India: Guidelines for management - IAA Consensus Document
Addendum
Announcement
Art & Psychiatry
Article
Articles
Association Activities
Association Notes
Award Article
Book Review
Brief Report
Case Analysis
Case Letter
Case Letters
Case Notes
Case Report
Case Reports
Clinical and Laboratory Investigations
Clinical Article
Clinical Studies
Clinical Study
Commentary
Conference Oration
Conference Summary
Continuing Medical Education
Correspondence
Corrigendum
Cosmetic Dermatology
Cosmetology
Current Best Evidence
Current Issue
Current View
Derma Quest
Dermato Surgery
Dermatopathology
Dermatosurgery Specials
Dispensing Pearl
Do you know?
Drug Dialogues
e-IJDVL
Editor Speaks
Editorial
Editorial Remarks
Editorial Report
Editorial Report - 2007
Editorial report for 2004-2005
Errata
Erratum
Focus
Fourth All India Conference Programme
From Our Book Shelf
From the Desk of Chief Editor
General
Get Set for Net
Get set for the net
Guest Article
Guest Editorial
History
How I Manage?
IADVL Announcement
IADVL Announcements
IJDVL Awards
IJDVL AWARDS 2015
IJDVL Awards 2018
IJDVL Awards 2019
IJDVL Awards 2020
IJDVL International Awards 2018
Images in Clinical Practice
Images in Dermatology
In Memorium
Inaugural Address
Index
Knowledge From World Contemporaries
Leprosy Section
Letter in Response to Previous Publication
Letter to Editor
Letter to the Editor
Letter to the Editor - Case Letter
Letter to the Editor - Letter in Response to Published Article
LETTER TO THE EDITOR - LETTERS IN RESPONSE TO PUBLISHED ARTICLES
Letter to the Editor - Observation Letter
Letter to the Editor - Study Letter
Letter to the Editor - Therapy Letter
Letter to the Editor: Articles in Response to Previously Published Articles
Letters in Response to Previous Publication
Letters to the Editor
Letters to the Editor - Letter in Response to Previously Published Articles
Letters to the Editor: Case Letters
Letters to the Editor: Letters in Response to Previously Published Articles
Media and news
Medicolegal Window
Messages
Miscellaneous Letter
Musings
Net Case
Net case report
Net Image
Net Images
Net Letter
Net Quiz
Net Study
New Preparations
News
News & Views
Obituary
Observation Letter
Observation Letters
Oration
Original Article
ORIGINAL CONTRIBUTION
Original Contributions
Pattern of Skin Diseases
Pearls
Pediatric Dermatology
Pediatric Rounds
Perspective
Presedential Address
Presidential Address
Presidents Remarks
Quiz
Recommendations
Regret
Report
Report of chief editor
Report of Hon : Treasurer IADVL
Report of Hon. General Secretary IADVL
Research Methdology
Research Methodology
Resident page
Resident's Page
Resident’s Page
Residents' Corner
Residents' Corner
Residents' Page
Retraction
Review
Review Article
Review Articles
Reviewers 2022
Revision Corner
Self Assessment Programme
SEMINAR
Seminar: Chronic Arsenicosis in India
Seminar: HIV Infection
Short Communication
Short Communications
Short Report
Snippets
Special Article
Specialty Interface
Studies
Study Letter
Study Letters
Supplement-Photoprotection
Supplement-Psoriasis
Symposium - Contact Dermatitis
Symposium - Lasers
Symposium - Pediatric Dermatoses
Symposium - Psoriasis
Symposium - Vesicobullous Disorders
SYMPOSIUM - VITILIGO
Symposium Aesthetic Surgery
Symposium Dermatopathology
Symposium-Hair Disorders
Symposium-Nails Part I
Symposium-Nails-Part II
Systematic Review and Meta-Analysis
Systematic Reviews and Meta-analyses
Systematic Reviews and Meta-analysis
Tables
Technology
Therapeutic Guideline-IADVL
Therapeutic Guidelines
Therapeutic Guidelines - IADVL
Therapeutics
Therapy
Therapy Letter
Therapy Letters
View Point
Viewpoint
What’s new in Dermatology
View/Download PDF

Translate this page into:

Letter to the Editor
2015:81:3;305-306
doi: 10.4103/0378-6323.152743
PMID: 25784226

Histiocytoid sweet syndrome related to bortezomib: A mimicker of cutaneous infiltration by myeloma

Mar Llamas-Velasco1 , Maria J Concha-Garzón1 , Javier Fraga2 , M Aragüés1
1 Department of Dermatology, Hospital Universitario De La Princesa, Madrid, Spain
2 Department of Pathology, Hospital Universitario De La Princesa, Madrid, Spain

Correspondence Address:
Mar Llamas-Velasco
C/Diego de León 62, CP28006, Madrid
Spain
How to cite this article:
Llamas-Velasco M, Concha-Garzón MJ, Fraga J, Aragüés M. Histiocytoid sweet syndrome related to bortezomib: A mimicker of cutaneous infiltration by myeloma. Indian J Dermatol Venereol Leprol 2015;81:305-306
Copyright: (C)2015 Indian Journal of Dermatology, Venereology, and Leprology

Sir,

Histiocytoid Sweet syndrome presents with lesions mimicking classical Sweet syndrome but histopathologically is characterized by an inflammatory infiltrate composed of monocytoid or histiocytoid cells positively stained with CD15, CD43, CD45, CD68, MAC-386, HAM56, myeloperoxidase, and lysozyme, which correspond with immature neutrophils. [1] This pattern is independent of the length of time the lesion has been present and can be demonstrated in lesions of less than 24 h duration. [1]

Several skin lesions associated with bortezomib have been described as skin rash which show histopathological findings of lymphocytic infiltrates, interphase dermatitis, [2] vasculitis, [3] and different neutrophilic diseases. [4],[5],[6],[7],[8],[9],[10],[11]

A 66-year-old male with an IgG lambda myeloma that progressed despite autologous peripheral blood stem cell transplantation was being treated with bortezomib (1.3 mg/m 2 ) and melphalan (9 mg/m 2 ) according to VISTA protocol (Velcade as Initial Standard Therapy in Multiple Myeloma). On the 8 th day of the second chemotherapy cycle, he presented with asymptomatic lesions on the trunk that had appeared 5 days earlier on his chest and remained stable. No fever, malaise, or systemic symptoms were present. On physical examination, he had 15-20 well-demarcated erythematous, slightly infiltrated, edematous plaques [Figure - 1]. Blood analysis showed neutropenia (2860/mm 3 with 39.2% neutrophils). Erythrocyte sedimentation rate was 54 mm.

Figure 1: (a) Nonconfluent, erythematous, and edematous well-demarcated plaques, slightly infiltrated and without epidermal involvement. (b) Closer view of the lesions

Skin biopsy revealed a perivascular, polymorphous, inflammatory infiltrate composed of lymphocytes and histiocyte-like cells [Figure - 2]. Histiocyte-like cells were positive for myeloperoxidase and lysozyme. Karyorrhexis was observed although vasculitis was not seen. Skin biopsy culture was negative. He did not receive treatment with granulocyte-macrophage-colony stimulating factor or other drugs known to be associated with Sweet′s syndrome. We made a diagnosis of histiocytoid Sweet′s syndrome related to bortezomib.

Figure 2: (a) Edema in papillary dermis. Polymorphous nodular infiltrates in reticular dermis and extravasation of erythrocytes (H and E, ×100). (b) Lymphocytes without atypical nuclei, scattered mature neutrophils and many histiocyte-like cells (H and E, ×200)

With intramuscular corticosteroid injection, the lesions disappeared but reappeared on the second day of the second part of the cycle. After this recurrence, he was treated with 20 mg prednisone for 4 days after every bortezomib treatment and did not develop any further recurrences.

Sweet′s syndrome related to multiple myeloma is infrequent, [9] but bortezomib-related neutrophilic diseases have been previously described with typical lesions that usually appear between the first and the third cycle. [4],[5],[6],[7],[8],[9],[10],[11] The presence of leucocytosis or fever may favor the diagnosis of myeloma associated-Sweet′s syndrome, but both findings were not present in our case unlike some other cases. [11] We were able to find only 2 previous cases of histiocytoid Sweet′s syndrome related to bortezomib. [4],[12] The main differential diagnoses of histiocytoid Sweet′s syndrome include interstitial granuloma annulare and interstitial granulomatous dermatitis, both showing a denser, "bottom-heavy," inflammatory infiltrate of histiocytes with large, pleomorphic nuclei that in some small foci are arranged in palisades surrounding degenerated basophilic collagen; [1] methotrexate-induced rheumatoid papules, which appears only in methotrexate-treated patients; and leukemia cutis that shows nodular dermal infiltrates of medium-sized, round to oval mononuclear cells that express lysozyme, myeloperoxidase, CD43, CD45, and CD68. Specific myeloma infiltration should be ruled out when evaluating presumed lesions of histiocytoid Sweet′s syndrome. A cytologic examination of peripheral blood should be performed and fluorescence in situ hybridization may be useful to detect underlying cytogenetic abnormalities in histiocytoid Sweet′s syndrome when there is an identifiable chromosomal abnormality. [13]

References
1.
Requena L, Kutzner H, Palmedo G, Pascual M, Fernandez-Herrera J, Fraga J, et al. Histiocytoid Sweet syndrome: A dermal infiltration of immature neutrophilic granulocytes. Arch Dermatol 2005;141:834-42.
[Google Scholar]
2.
Garcia-Navarro X, Puig L, Fernandez-Figueras MT, Dalmau J, Roe E, Alomar A. Bortezomib-associated cutaneous vasculitis. Br J Dermatol 2007;157:799-801.
[Google Scholar]
3.
Agterof MJ, Biesma DH. Images in clinical Medicine. Bortezomib-induced skin lesions. N Engl J Med 2005;352:2534.
[Google Scholar]
4.
Murase JE, Wu JJ, Theate I, Cole GW, Barr RJ, Dyson SW. Bortezomib-induced histiocytoid Sweet syndrome. J Am Acad Dermatol 2009;60:496-7.
[Google Scholar]
5.
Van Regenmortel N, Van de Voorde K, De Raeve H, Rombouts S, Van de Velde A, Lambert J, et al. Bortezomib-induced Sweet's syndrome. Haematologica 2005;90:43.
[Google Scholar]
6.
Liu CI, Hsiao CH, Wu JT, Tsai TF. Sweet syndrome with histiocytoid infiltrate and neutropenia: A rare combination. J Am Acad Dermatol 2009;61:882-4.
[Google Scholar]
7.
Knoops L, Jacquemain A, Tennstedt D, Theate I, Ferrant A, Van den Neste E. Bortezomib-induced Sweet syndrome. Br J Haematol 2005;131:142.
[Google Scholar]
8.
Paiva CM, Kurtis B, Mekki M, Newman MA, Singhal S, Lacouture ME. Neutrophilic dermatitis associated with bortezomib in a patient with multiple myeloma. Ann Oncol 2007;18:1744-5.
[Google Scholar]
9.
Tanguy-Schmidt A, Avenel-Audran M, Croue A, Lissandre S, Dib M, Zidane-Marinnes M, et al. Bortezomib-induced acute neutrophilic dermatosis. Ann Dermatol Venereol 2009;136:443-6.
[Google Scholar]
10.
Thomas M, Cavelier Balloy B, Andreoli A, Briere J, Petit A. Bortezomib-induced neutrophilic dermatosis with CD30+lymphocytic infiltration. Ann Dermatol Venereol 2009;136:438-42.
[Google Scholar]
11.
Thuillier D, Lenglet A, Chaby G, Royer R, Vaida I, Viseux V, et al. Bortezomib-induced eruption: Sweet syndrome? Two case reports. Ann Dermatol Venereol 2009;136:427-30.
[Google Scholar]
12.
Kim JS, Roh HS, Lee JW, Lee MW, Yu HJ. Distinct variant of Sweet's syndrome: Bortezomib-induced histiocytoid Sweet's syndrome in a patient with multiple myeloma. Int J Dermatol 2012;51:1491-3.
[Google Scholar]
13.
Chavan RN, Cappel MA, Ketterling RP, Wada DA, Rochet NM, Knudson R, et al. Histiocytoid Sweet syndrome may indicate leukemia cutis: A novel application of fluorescence in situ hybridization. J Am Acad Dermatol 2014;70:1021-7.
[Google Scholar]

Fulltext Views
3,262

PDF downloads
808
Show Sections